TY - JOUR
T1 - A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1
AU - Rozenfeld-Granot, Galit
AU - Krishnamurthy, Janakiraman
AU - Kannan, Karuppiah
AU - Toren, Amos
AU - Amariglio, Ninette
AU - Givol, David
AU - Rechavi, Gideon
N1 - Funding Information:
We thank Dr Moshe Oren for the baculovirus recombinant p53, the p53 cDNA constructs and pAb421 and for helpful discussion. We thank Dr M Stallcup for the Zac-1 construct and Dr X Wang for the Apaf-1 construct. This work was supported in part by the Arison Dorsman donation, the Yad Abraham Center for Cancer Diagnosis and Therapy and the Germany Israel Science Foundation (GIF). G Rechavi holds the Gregorio and Dora Shapiro Chair for Hematology Malignancies, Sackler School of Medicine Tel Aviv University. Part of this work was performed in partial fulfilment of the requirement of the Ph. D. degree of Galit Rozenfeld-Granot, Sackler Faculty of Medicine, Tel Aviv University.
PY - 2002
Y1 - 2002
N2 - p53 exerts its tumor suppressor effects by activating genes involved in cell growth arrest and programmed cell death. The p53 target genes inducing growth arrest are well defined whereas those inducing apoptosis are not fully characterized. Proapoptotic activity of p53 was shown to involve several genes like Bax, Noxa and Puma, which may function in the release of cytochrome c from the mitochondria. Cytochrome c associates with Apaf-1 and caspase 9 to form the apoptosome. Genetic and cellular data indicate that Apaf-1 deficiency abrogates the apoptotic effect of p53 and substitutes for p53 loss in promoting tumor formation. Here we show that Apaf-1, the mammalian homologue of C. elegans CED4, is a direct target of p53 as demonstrated by gel shift analysis of the target site sequence in the presence of p53 and by Apaf-1 promoter-luciferase assays. We also show that the p53 activation of the Apaf-1 luciferase construct can be enhanced by the putative tumor suppressor gene product, Zac-1, a transcription factor that has previously been shown to inhibit cell proliferation. Furthermore, we demonstrate that Zac-1 is a possible direct target of p53 since the sequence upstream to the first coding exon of Zac-1 contains a p53 recognition site and the luciferase construct containing this region is activated by p53. These results suggests the existence of a tightly controlled self amplifying mechanism of transcriptional activation leading to apoptosis by p53.
AB - p53 exerts its tumor suppressor effects by activating genes involved in cell growth arrest and programmed cell death. The p53 target genes inducing growth arrest are well defined whereas those inducing apoptosis are not fully characterized. Proapoptotic activity of p53 was shown to involve several genes like Bax, Noxa and Puma, which may function in the release of cytochrome c from the mitochondria. Cytochrome c associates with Apaf-1 and caspase 9 to form the apoptosome. Genetic and cellular data indicate that Apaf-1 deficiency abrogates the apoptotic effect of p53 and substitutes for p53 loss in promoting tumor formation. Here we show that Apaf-1, the mammalian homologue of C. elegans CED4, is a direct target of p53 as demonstrated by gel shift analysis of the target site sequence in the presence of p53 and by Apaf-1 promoter-luciferase assays. We also show that the p53 activation of the Apaf-1 luciferase construct can be enhanced by the putative tumor suppressor gene product, Zac-1, a transcription factor that has previously been shown to inhibit cell proliferation. Furthermore, we demonstrate that Zac-1 is a possible direct target of p53 since the sequence upstream to the first coding exon of Zac-1 contains a p53 recognition site and the luciferase construct containing this region is activated by p53. These results suggests the existence of a tightly controlled self amplifying mechanism of transcriptional activation leading to apoptosis by p53.
KW - Apaf-1
KW - Apoptosis
KW - Promoter luciferase assay
KW - Zac-1 coactivation
KW - p53 target
UR - http://www.scopus.com/inward/record.url?scp=85047696901&partnerID=8YFLogxK
U2 - 10.1038/sj.onc.1205218
DO - 10.1038/sj.onc.1205218
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 11896574
AN - SCOPUS:85047696901
VL - 21
SP - 1469
EP - 1476
JO - Oncogene
JF - Oncogene
SN - 0950-9232
IS - 10
ER -